Evidence map›Paper›PMID 32650271›Full record

ArticleEBioMedicine2020

Corrigendum to 'Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid x receptor': [EBioMedicine 54 (2020) 102719].

Raffaella Maria Gadaleta, Oihane Garcia-Irigoyen, Marica Cariello, Natasha Scialpi, Claudia Peres, Stefania Vetrano, Gionatha Fiorino, Silvio Danese, Brian Ko, Jian Luo and 4 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Raffaella Maria GadaletaDepartment of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy; National Institute for Biostructures and Biosystems, Via delle Medaglie d'Oro 135, 00136 Rome, Italy.
Oihane Garcia-IrigoyenDepartment of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy.
Marica CarielloDepartment of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy.
Natasha ScialpiNational Institute for Biostructures and Biosystems, Via delle Medaglie d'Oro 135, 00136 Rome, Italy.
Claudia PeresNational Institute for Biostructures and Biosystems, Via delle Medaglie d'Oro 135, 00136 Rome, Italy.
Stefania VetranoDepartment of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS-, via Manzoni 56, 20089 Rozzano, Milan, Italy.
Gionatha FiorinoDepartment of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS-, via Manzoni 56, 20089 Rozzano, Milan, Italy.
Silvio DaneseDepartment of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS-, via Manzoni 56, 20089 Rozzano, Milan, Italy.
Brian KoNGM Biopharmaceuticals Inc., 333 Oyster Point Blvd, South San Francisco, CA 94080, United States.
Jian LuoNGM Biopharmaceuticals Inc., 333 Oyster Point Blvd, South San Francisco, CA 94080, United States.
Emanuele PorruDepartment of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Via Selmi, 2, 40126 Bologna, Italy.
Aldo RodaDepartment of Chemistry "Giacomo Ciamician", Alma Mater Studiorum, University of Bologna, Via Selmi, 2, 40126 Bologna, Italy.
Carlo SabbáDepartment of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy.
Antonio MoschettaDepartment of Interdisciplinary Medicine, "Aldo Moro" University, Piazza Giulio Cesare 11, 70124 Bari, Italy; National Cancer Center, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco, 65, 70124 Bari, Italy. Electronic address: antonio.moschetta@uniba.it.
University of Bari Aldo Moro · ITHumanitas University · ITNGM Biopharmaceuticals (United States) · USUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32650271
PMCPMC7348001
OpenAlexW3040693965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.